Literature DB >> 14611826

Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity.

M Bountioukos1, J K Doorduijn, J R T C Roelandt, E C Vourvouri, J J Bax, A F L Schinkel, M D Kertai, P Sonneveld, D Poldermans.   

Abstract

AIMS: To evaluate whether repetitive assessment of systolic and diastolic cardiac function by dobutamine stress echocardiography (DSE) can predict anthracycline cardiotoxicity. METHODS AND
RESULTS: Thirty-one patients (age, 57+/-13 years, 22 male) were studied before chemotherapy, with follow-ups during, at the end, and 6 months after chemotherapy. Left ventricular (LV) function was assessed by two-dimensional (2D) echocardiographic wall motion score index (WMSI) and by Doppler echocardiography of mitral valve inflow at rest and during DSE. Radionuclide ventriculography was used as an independent reference for ejection fraction (EF). A reduction of EF >/=5% occurred in 17 patients (group A) at the last follow-up. Patients without decreased EF comprised group B. Early/late diastolic velocity of mitral inflow (E/A ratio) at rest was lower in group A (0.91+/-0.2 vs 1.28+/-0.3, P<0.001), and it was an independent predictor of cardiotoxicity (adjusted for baseline patient characteristics and parameters of systolic and diastolic function). At follow-up, WMSI at rest paralleled radionuclide EF. Contractile reserve at low-dose DSE was preserved in group A.
CONCLUSIONS: WMSI measured by 2D echocardiography parallels radionuclide EF at follow-up. Assessment of contractile reserve has no incremental value for the early detection of cardiotoxicity. A baseline abnormal E/A ratio is an independent predictor of anthracycline cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611826     DOI: 10.1016/s1525-2167(03)00017-9

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  16 in total

1.  Advanced Echocardiographic Techniques in Detection of Cardiotoxicity.

Authors:  Aarti A Patel; Arthur J Labovitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

2.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10       Impact factor: 6.875

Review 3.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 4.  Current views on anthracycline cardiotoxicity.

Authors:  Donato Mele; Marianna Nardozza; Paolo Spallarossa; Antonio Frassoldati; Carlo G Tocchetti; Christian Cadeddu; Rosalinda Madonna; Michele Malagù; Roberto Ferrari; Giuseppe Mercuro
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 5.  Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs.

Authors:  Ronny S Jiji; Christopher M Kramer; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

6.  Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-12-01

7.  Cardiac complications of chemotherapy: role of imaging.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

8.  Detection and monitoring of cardiotoxicity-what does modern cardiology offer?

Authors:  Ruxandra Jurcut; Hans Wildiers; Javier Ganame; Jan D'hooge; Robert Paridaens; Jens-Uwe Voigt
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

Review 9.  Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.

Authors:  Aaron Soufer; Chi Liu; Mariana L Henry; Lauren A Baldassarre
Journal:  J Nucl Cardiol       Date:  2019-03-13       Impact factor: 3.872

Review 10.  Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment.

Authors:  Yehia Saleh; Ola Abdelkarim; Khader Herzallah; George S Abela
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.